
Kinases are a large class of enzymes that are crucial to the proper operation of many cellular processes including cell growth, metabolism and apoptosis. Protein kinases use ATP to phosphorylate proteins within a cell, modifying the target protein’s function in some manner. Since abnormally functioning protein kinases are involved in the pathogenesis of many diseases, these enzymes are often drug therapy targets. Protein kinase inhibitors are small molecules, polypeptides, or antibodies that block or diminish kinase function. In research, they are often used in kinase inhibition assays, ultimately leading to the identification of appropriate therapeutic targets and the development of effective treatments. There is a growing list of FDA-approved kinase inhibitor drugs that treat a myriad of diseases such as cancer, autoimmune disorders, inflammatory disorders, and glaucoma. Some examples include:
MEK Inhibitors - BRAF-V600E positive advanced melanoma (Trametinib)
JAK Inhibitors - myelofibrosis (Ruxolitinib)
PI3K Inhibitors - Chronic lymphocytic leukemia (Idelalisib)
Both mass spec & non-mass spec methods are expanding the field
read more
Identify proper methods and tools for your experimental workflows
read more
Set up a live demo with a Bio-Rad Imaging Specialist - Request a DemoUse the ChemiDoc MP Imaging System for flexible, high-sensitivity multiplex fluorescent and chemiluminescence western blot detection, imaging gels, analysis and documentation. This ...
read more
The Sapphire FL Biomolecular Imager is a field-upgradable laser scanner, with a wide selection of user-adjustable lasers and filters. It features 5-micron resolution, adjustable Z-plane focus and a wide field of view of 25cm X 25cm. Applications ...
read more
We used this Wortmannin to inhibit PI3K and other it's role in other phospholipids or signaling molecules.
read more
In our cell culture, Trypsin inhibitors are used in cell culture experiments to further inhibit tryptic activity during cell dissociation to prevent cell damage/death.
read more